ResMed Inc. (RMD) Covered Calls

ResMed Inc. covered calls ResMed is a global leader in digital health and connected medical devices, primarily focused on the treatment of sleep-disordered breathing, COPD, and other chronic respiratory conditions. The company provides innovative cloud-connected solutions that empower patients to manage their care from home, while supporting healthcare professionals with data-driven insights. Its technology aims to improve quality of life, reduce hospitalizations, and lower costs across global healthcare systems.

You can sell covered calls on ResMed Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RMD (prices last updated Tue 4:16 PM ET):

ResMed Inc. (RMD) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
247.11 -5.82 246.17 275.55 930K 25 37
Covered Calls For ResMed Inc. (RMD)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Mar 20 250 3.30 272.25 -8.2% -272.1%
Apr 17 250 7.80 267.75 -6.6% -61.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


ResMed operates at the intersection of medical device technology and digital health. The company is best known for its comprehensive ecosystem of devices—including CPAP machines and masks—designed to treat sleep apnea and other respiratory issues. A defining feature of its business model is the integration of cloud-connected software, which allows patients, physicians, and home medical equipment providers to monitor therapy effectiveness in real time. This digital connectivity transforms the patient experience from reactive to proactive care.

Beyond its core sleep and respiratory business, the company provides sophisticated software platforms for out-of-hospital healthcare settings. These platforms help manage workflows for home health, hospice, and long-term care providers, further cementing the firm's role in modernizing home-based healthcare. By prioritizing data analytics and user-centric design, the firm consistently delivers solutions that enhance clinical outcomes and operational efficiency for caregivers and patients alike.

Competition

The market for sleep and respiratory care is characterized by intense innovation and the need for seamless digital integration. ResMed competes with a variety of specialized medical technology companies and diversified healthcare providers. Key publicly traded, optionable competitors include Stryker, Medtronic, and DexCom.

Strategic Outlook and Innovation

The company remains focused on expanding its digital health leadership by scaling its global monitoring ecosystem and refining its AI-driven diagnostic tools. A core strategic priority is to continue the transition of patient care from hospitals to the home setting, which remains a long-term structural trend in global healthcare. The firm continues to invest in R&D to improve the comfort, efficacy, and ease-of-use of its connected devices.

Innovation is centered on the further integration of data analytics to predict patient outcomes and intervene before complications arise. By leveraging its vast repository of clinical respiratory data, the company seeks to personalize therapy and enhance the precision of its treatments. Through disciplined expansion into adjacent medical categories and a focus on operational excellence, the firm aims to sustain its growth and remain a primary partner for health systems worldwide.

 
Top 10 Open Interest For Mar 20 Expiration     Top 5 High Yield
1.NVDA covered calls 6.QQQ covered calls   1.CTMX covered calls
2.SLV covered calls 7.EWZ covered calls   2.PATH covered calls
3.EEM covered calls 8.FXI covered calls   3.USO covered calls
4.SPY covered calls 9.GLD covered calls   4.FLY covered calls
5.IBIT covered calls 10.KWEB covered calls   5.ONDS covered calls

Want more examples? |

Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.

Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.

No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.

You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.